SCHEMBL3142284

SCHEMBL3142284

CCCc1cc(C)c2cc(Oc3c(Br)cc(OCC(=O)O)cc3Br)cc(F)c2n1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
THRB P10828 7/20 0.34
THRA P10827 6/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
PDE10A Q9Y233 1/20 0.33
HSD17B10 Q99714 2/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
PTPRB P23467 1/20 0.33
PPARD Q03181 4/20 0.32
PPARG P37231 3/20 0.32
PPARA Q07869 2/20 0.32
MIF P14174 1/20 0.32
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
KMT2A Q03164 1/20 0.32
FFAR1 O14842 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3146227 0.88 PPARD (0.40) HPGDKDM4EALDH1A1PPARDPPARG
SCHEMBL3140929 0.86 THRA (0.43) THRBTHRAPPARG
SCHEMBL3138058 0.84 THRA (0.41) THRBTHRAHPGDKDM4EALDH1A1
SCHEMBL3141250 0.82 THRA (0.37) THRBTHRAPPARGFFAR1
Propionic Acid SCHEMBL5074391 0.82 THRA (0.35) THRBTHRAPPARG
SCHEMBL3145925 0.78 THRA (0.45) THRBTHRAPPARG
SCHEMBL5074394 0.77 THRA (0.32) THRBTHRAPPARG
SCHEMBL3141371 0.77 EGLN1 (0.38) THRBTHRA
SCHEMBL3145653 0.77 THRA (0.48) THRBTHRAPPARGPOLB
SCHEMBL3127311 0.76 THRA (0.45) THRBTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004271-A1 HETEROCYCLIC COMPOUNDS AS AGANIST FOR THE THYROID RECEPTOR KARO BIO AB (SE) 2010-01-07 US disclosed
WO-2009080835-A1 THYROMIMETRIC COMPOUNDS IN TREATMENT OF DISEASE RELATED TO SONIC HEDGEHOG SIGNALLING KARO BIO AB (SE) 2009-07-02 WO disclosed
EP-1899309-A1 HETEROCYCLIC COMPOUNDS AS AGONISTS FOR THE THYROID RECEPTOR KARO BIO AB (SE) 2008-03-19 EP disclosed
WO-2007003419-A1 HETEROCYCLIC COMPOUNDS AS AGONISTS FOR THE THYROID RECEPTOR KARO BIO AB (SE) 2007-01-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004271-A1 HETEROCYCLIC COMPOUNDS AS AGANIST FOR THE THYROID RECEPTOR TSHR, GHSR, TRHR THRB 6/4885THRA 4/4885HPGD 1390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.